Hints and tips:
Related Special Reports
Related Topics
...Dr Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases, or NIAID, told the Financial Times that the records could help resolve the debate over the origins of a disease that...
...Read more on Fauci’s plan to step down as head of NIAID here...
...Fauci said on Monday he would leave his positions as both head of the NIAID and as chief medical adviser to US president Joe Biden in the coming months to “pursue the next chapter of my career”....
...He told the FT he would be standing aside from that role as well when he leaves NIAID....
...“Dr Fauci will isolate and continue to work from his home,” the NIAID said....
...The phase 2 trial is being conducted by the NIAID-funded Autoimmunity Centers of Excellence....
...Those two things are similar for Covid,” says John Mascola, director of vaccine research at the US’s NIAID....
...that could be taken at home early in the course of disease, would be powerful tools for battling the pandemic and saving lives,” said Dr Anthony Fauci, chief medical adviser to President Joe Biden and NIAID...
...As head of NIAID, Fauci was ultimately responsible for government grants for gain of function work....
...The NIAID said it had urged AstraZeneca “to work with the DSMB to review the efficacy data and ensure the most accurate, up-to-date efficacy data be made public as quickly as possible”....
...NIAID funded that work by between $300,000 and $600,000 a year until 2017....
...It had been seen as a significant opportunity for the drugmaker to reverse its fortunes in the US, though the NIAID warning has damped those hopes....
...Merdad Parsey, Gilead’s chief medical officer, said its trial “complements” the placebo-controlled study by NIAID....
...Scientists are clamouring for the full results of the NIAID study as they consider how to administer the drug....
...The NIAID trial enrolled more than 1,000 across the world....
...A study by the National Institute of Allergy and Infectious Diseases (NIAID) found that remdesivir shortened the recovery time for virus patients by four days on average....
...Anthony Fauci (Director of NIAID) has said scientists are hoping for a vaccine that is at least 75% effective, but that 50% or 60% effective would be acceptable (link)....
...This article has been amended since initial publication to correct that Anthony Fauci has been in his position at the NIAID since 1984...
...The full data would be for NIAID to publish, it said. Dr Licholai said many biotech companies issue press releases on early data. “Yet Stéphane does it and he gains something billions in market value?...
...We think the NIAID study readout is meaningful and could lead to an approval for remdesivir before the moderate trial reads out....
...received one of four different treatments of which REGN-EB3 and mAb114 proved to be most effective and will now be administered to all patients until the completion of the trial at the end of September, the NIAID...
...NIAID researchers used a development strategy that had produced a candidate vaccine against West Nile virus....
...NIAID, with other public agencies and companies, is developing long-acting forms of HIV prevention with formulations of antiretroviral drugs that need only be administered monthly or even annually....
International Edition